DIVI'S LABORATORIES LTD. - Clarifies on News Item

Download	< Back
23 Dec 2016
With reference to news appeared in CNBC TV 18 dated December 23, 2016 quoting "Emkay says on Vizag 483 observation:<BR><BR>1. proper control not being exercised over computer system<BR>2. facility equipments not maintained to ensure purity quality strength<BR>3. documentation and records not maintained or inaccurate falsified "<BR><BR>Divis Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.
View all announcements for DIVI'S LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us